TNDM R&D Expense Growth
Tandem Diabetes Care Inc · R&D Expense Growth
TNDM R&D Expense Growth
Latest reported-12.09%period ending
TNDM FY R&D Growth (YoY) (0.00% → -12.09%)
Latest values, visible window
High-resolution chart · PNG
TNDM r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -12.0884% | |
| -19.9423% | |
| 45.9963% | |
| 84.8404% | |
| 44.7982% | |
| 40.6536% | |
| 54.6481% | |
| 41.4598% | |
| 9.8464% | |
| 10.8825% | |
| 7.4219% | |
| 42.5283% | |
| 22.9788% | |
| 9.0574% | |
| 0% |